Fundraising Fox

world

5 known investors

delfidiagnostics.com

DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening. The test offers an alternative to low-dose CT imaging for patients meeting USPSTF criteria and is made available to health systems, primary care providers, and lung screening programs.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devicesin /delfi-diagnostics

Investors · 5

In the news